ESC 365 - Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-Term Registry: bridging between the PARADIGM-HF trial, ESC Guidelines and real-world

HFA Premium Access

Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-Term Registry: bridging between the PARADIGM-HF trial, ESC Guidelines and real-world

Session: Late breaking trial IV - Registries

Topic: Pharmacotherapy

Speaker: Doctor C. Kapelios (Athens, GR)

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Presentation

About the speaker

Doctor Chris Kapelios

Laiko University General Hospital, Athens (Greece)

2 presentations

0 follower

10 more presentations in this session

Prospective evaluation of natriuretic peptide based referral of chronic heart failure patients in primary care (PREFER): a pragmatic real world intervention study

Speaker: Professor F. Gustafsson (Copenhagen, DK)

Discussion - PREFER.

Discussion - PARADIGM-HF.

Clinical presentation, management and 6-month outcome of women diagnosed with PPCM from Europe, Africa, Asia Pacific and Middle East

Speaker: Professor K. Sliwa-Hahnle (Cape Town, ZA)

Discussion - Clinical presentation, management and 6-month outcome of women diagnosed with PPCM from Europe, Africa, Asia Pacific and Middle East.

Outcomes after hospitalization for acute heart failure across regions at different economic levels: results from the REPORT-HF registry

Speaker: Doctor S. Collins (Nashville, US)

Discussion - REPORT-HF.

Comparative effectiveness of CABG and PCI in patients with ischemic heart failure: insights from the swedish coronary angiography and angioplasty registry

Speaker: Professor E. Omerovic (Gothenburg, SE)

Discussion - Comparative effectiveness of CABG and PCI in patients with ischemic heart failure: insights from the swedish coronary angiography and angioplasty registry.

Panel Discussion.